[
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific",
    "summary": "Zacks spotlights NVIDIA, Micron and Thermo Fisher in its latest Analyst Blog, highlighting AI-driven tailwinds, memory-market momentum and ongoing innovation across life sciences.",
    "url": "https://finnhub.io/api/news?id=9272dd9c9de4a814065ba29bccdaec1955bb7869b955aaacd9dc7cd8572465d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763127840,
      "headline": "The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific",
      "id": 137480283,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Zacks spotlights NVIDIA, Micron and Thermo Fisher in its latest Analyst Blog, highlighting AI-driven tailwinds, memory-market momentum and ongoing innovation across life sciences.",
      "url": "https://finnhub.io/api/news?id=9272dd9c9de4a814065ba29bccdaec1955bb7869b955aaacd9dc7cd8572465d9"
    }
  },
  {
    "ts": null,
    "headline": "If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now",
    "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
    "url": "https://finnhub.io/api/news?id=f7ed6a65a0e8a453e0383d98a0b21f5432693889dda5a1b5d36933c83a639b6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763127004,
      "headline": "If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now",
      "id": 137480317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
      "url": "https://finnhub.io/api/news?id=f7ed6a65a0e8a453e0383d98a0b21f5432693889dda5a1b5d36933c83a639b6d"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Value Fund Q3 2025 Top Contributors And Detractors",
    "summary": "Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo.",
    "url": "https://finnhub.io/api/news?id=d239ca4796e9f576db683f406fe0ac06d13e000b175d9c5ba8ed82e6408a06ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763124600,
      "headline": "Artisan Value Fund Q3 2025 Top Contributors And Detractors",
      "id": 137481012,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo.",
      "url": "https://finnhub.io/api/news?id=d239ca4796e9f576db683f406fe0ac06d13e000b175d9c5ba8ed82e6408a06ed"
    }
  },
  {
    "ts": null,
    "headline": "Recombinant Human Fibroblast Growth Factor Global Market Forecast 2025-2030: Markets Benefit from Strategic Investments and Collaborations",
    "summary": "Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound healing, tissue engineering, and cosmetics. Notable firms include Thermo Fisher and Merck.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The \"Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030\" report has been added to ResearchAndMarkets.com's offering. Recombinant human fibrobla",
    "url": "https://finnhub.io/api/news?id=464e451357a0d773a8224cab56c0563a4083c50f620d9752145f0ebee61abcd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763112600,
      "headline": "Recombinant Human Fibroblast Growth Factor Global Market Forecast 2025-2030: Markets Benefit from Strategic Investments and Collaborations",
      "id": 137478298,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound healing, tissue engineering, and cosmetics. Notable firms include Thermo Fisher and Merck.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The \"Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030\" report has been added to ResearchAndMarkets.com's offering. Recombinant human fibrobla",
      "url": "https://finnhub.io/api/news?id=464e451357a0d773a8224cab56c0563a4083c50f620d9752145f0ebee61abcd9"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Digital Transformation and Innovation Strategy, Technology Initiatives, Investments, and Acquisitions",
    "summary": "Thermo Fisher presents market opportunities through digital transformation, innovation programs, and strategic tech initiatives. They leverage partnerships, product launches, and acquisitions across segments like Life Sciences, Analytical Instruments, and Diagnostics, aiding pharmaceuticals, research, and healthcare sectors.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The \"Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025\" company profile has been added to ResearchAndMarkets.com's o",
    "url": "https://finnhub.io/api/news?id=9ed59364e510fd3a0771b7d28008d37463b83dc26eca5542b1f277c0d288bf3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763111580,
      "headline": "Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Digital Transformation and Innovation Strategy, Technology Initiatives, Investments, and Acquisitions",
      "id": 137478299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher presents market opportunities through digital transformation, innovation programs, and strategic tech initiatives. They leverage partnerships, product launches, and acquisitions across segments like Life Sciences, Analytical Instruments, and Diagnostics, aiding pharmaceuticals, research, and healthcare sectors.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The \"Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025\" company profile has been added to ResearchAndMarkets.com's o",
      "url": "https://finnhub.io/api/news?id=9ed59364e510fd3a0771b7d28008d37463b83dc26eca5542b1f277c0d288bf3d"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific (TMO): Assessing Valuation After a 10% Monthly Share Price Surge",
    "summary": "Thermo Fisher Scientific (TMO) has caught investors’ attention lately as its shares climbed more than 10% over the past month. The company’s strong recent momentum has some market watchers reassessing its long-term prospects. See our latest analysis for Thermo Fisher Scientific. After a period of sluggishness earlier this year, Thermo Fisher Scientific's 10% share price surge over the past month stands out. This supports a positive year-to-date gain and helps lift its one-year total...",
    "url": "https://finnhub.io/api/news?id=ebca47169fd85e809f5a8a3be1f9ed9958ab5d5e65e9bc626c9a17d67df27e43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763100613,
      "headline": "Thermo Fisher Scientific (TMO): Assessing Valuation After a 10% Monthly Share Price Surge",
      "id": 137476944,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific (TMO) has caught investors’ attention lately as its shares climbed more than 10% over the past month. The company’s strong recent momentum has some market watchers reassessing its long-term prospects. See our latest analysis for Thermo Fisher Scientific. After a period of sluggishness earlier this year, Thermo Fisher Scientific's 10% share price surge over the past month stands out. This supports a positive year-to-date gain and helps lift its one-year total...",
      "url": "https://finnhub.io/api/news?id=ebca47169fd85e809f5a8a3be1f9ed9958ab5d5e65e9bc626c9a17d67df27e43"
    }
  },
  {
    "ts": null,
    "headline": "Moat Stocks Climb In A Concentrated Market",
    "summary": "Moat Index outpaced the S&P 500 in October, driven by strong stock selection. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=9834467b09730772bb3529c1ed47f1fec0cd1dd6d46d4246d240412f37c8af81",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763083800,
      "headline": "Moat Stocks Climb In A Concentrated Market",
      "id": 137476699,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205719811/image_2205719811.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Moat Index outpaced the S&P 500 in October, driven by strong stock selection. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=9834467b09730772bb3529c1ed47f1fec0cd1dd6d46d4246d240412f37c8af81"
    }
  }
]